Impact of SARS-CoV-2 Epidemic on Antimicrobial Resistance: A Literature Review.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
20 10 2021
Historique:
received: 23 09 2021
revised: 12 10 2021
accepted: 15 10 2021
entrez: 27 11 2021
pubmed: 28 11 2021
medline: 15 12 2021
Statut: epublish

Résumé

Antimicrobial resistance is an urgent threat to public health and global development; in this scenario, the SARS-CoV2 pandemic has caused a major disruption of healthcare systems and practices. A narrative review was conducted on articles focusing on the impact of COVID-19 on multidrug-resistant gram-negative, gram-positive bacteria, and fungi. We found that, worldwide, multiple studies reported an unexpected high incidence of infections due to methicillin-resistant

Identifiants

pubmed: 34834917
pii: v13112110
doi: 10.3390/v13112110
pmc: PMC8624326
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

J Fungi (Basel). 2021 Apr 08;7(4):
pubmed: 33917967
Antibiotics (Basel). 2021 May 11;10(5):
pubmed: 34065029
Curr Opin Infect Dis. 2020 Aug;33(4):290-297
pubmed: 32657965
J Infect Dev Ctries. 2021 Jan 31;15(1):58-68
pubmed: 33571146
Clin Microbiol Infect. 2021 Jan 8;:
pubmed: 33429028
Eur J Clin Microbiol Infect Dis. 2021 Mar;40(3):495-502
pubmed: 33389263
Microbes Infect. 2021 May-Jun;23(4-5):104806
pubmed: 33684520
Am J Respir Crit Care Med. 2020 Jul 15;:
pubmed: 32668167
Sci Transl Med. 2019 Apr 10;11(487):
pubmed: 30971455
Lancet Respir Med. 2020 Jun;8(6):e48-e49
pubmed: 32445626
Infect Disord Drug Targets. 2021 Feb 03;:
pubmed: 33538678
Intensive Care Med. 2020 May;46(5):854-887
pubmed: 32222812
Emerg Infect Dis. 2008 Aug;14(8):1187-92
pubmed: 18680640
Ann Intensive Care. 2020 Jun 1;10(1):71
pubmed: 32488446
Enferm Infecc Microbiol Clin (Engl Ed). 2020 Dec 3;:
pubmed: 33413990
J Clin Med. 2020 Nov 27;9(12):
pubmed: 33260943
Clin Microbiol Infect. 2021 Apr;27(4):520-531
pubmed: 33418017
Lancet Infect Dis. 2021 Jun;21(6):e149-e162
pubmed: 33333012
Antibiotics (Basel). 2021 May 29;10(6):
pubmed: 34072342
Front Microbiol. 2020 Dec 15;11:590683
pubmed: 33384670
Clin Infect Dis. 2021 Jun 1;72(11):2021-2024
pubmed: 32941593
Antimicrob Resist Infect Control. 2020 Sep 22;9(1):154
pubmed: 32962759
N Engl J Med. 2010 May 13;362(19):1804-13
pubmed: 20463340
Med Mycol Case Rep. 2021 Mar;31:11-14
pubmed: 32837879
Crit Care. 2021 Jun 7;25(1):197
pubmed: 34099016
MMWR Morb Mortal Wkly Rep. 2020 Dec 04;69(48):1827-1831
pubmed: 33270611
Nat Rev Dis Primers. 2018 May 31;4:18033
pubmed: 29849094
Engineering (Beijing). 2020 Oct;6(10):1178-1184
pubmed: 33520333
Infect Drug Resist. 2020 Aug 03;13:2673-2680
pubmed: 32821131
Infect Drug Resist. 2020 May 05;13:1287-1294
pubmed: 32440165
Emerg Infect Dis. 2020 Nov;26(11):2694-2696
pubmed: 32852265
Int J Environ Res Public Health. 2021 Aug 19;18(16):
pubmed: 34444511
Clin Infect Dis. 2021 Jun 15;72(12):e995-e1003
pubmed: 33216875
Front Cell Infect Microbiol. 2020 Nov 24;10:572912
pubmed: 33330122
Clin Infect Dis. 2012 Sep;55(6):807-15
pubmed: 22700828
GMS Hyg Infect Control. 2020 Nov 27;15:Doc29
pubmed: 33299742
Clin Infect Dis. 2011 Jul 15;53(2):144-9
pubmed: 21690621
Clin Infect Dis. 2021 Jul 15;73(2):e445-e454
pubmed: 32651997
Clin Infect Dis. 2021 Oct 5;73(7):e1634-e1644
pubmed: 32860682
Clin Infect Dis. 2021 Apr 26;72(8):1314-1322
pubmed: 32129438
BMJ Case Rep. 2021 Jun 17;14(6):
pubmed: 34140329
Crit Care. 2019 Nov 21;23(1):371
pubmed: 31752976
Infect Control Hosp Epidemiol. 2021 Mar 09;:1-3
pubmed: 33685542
J Fungi (Basel). 2021 Feb 15;7(2):
pubmed: 33672021
J Fungi (Basel). 2020 Oct 08;6(4):
pubmed: 33050019
Clin Microbiol Infect. 2020 Dec;26(12):1622-1629
pubmed: 32711058
Int J Antimicrob Agents. 2020 Dec;56(6):106179
pubmed: 32987104
J Fungi (Basel). 2020 Jun 06;6(2):
pubmed: 32517166
Clin Infect Dis. 2021 Jan 29;72(Suppl 1):S17-S26
pubmed: 33512523
Am J Trop Med Hyg. 2019 Apr;100(4):943-951
pubmed: 30793684
Crit Care Med. 2021 Jan 1;49(1):e31-e40
pubmed: 33122577
Infect Control Hosp Epidemiol. 2021 Sep;42(9):1156-1158
pubmed: 32843125
Infection. 2021 Jun;49(3):559-562
pubmed: 33393065
Microorganisms. 2021 Jan 03;9(1):
pubmed: 33401591
Emerg Infect Dis. 2020 Sep;26(9):
pubmed: 32441243
Mycoses. 2021 Sep;64(9):1062-1072
pubmed: 34009677
Infect Control Hosp Epidemiol. 2021 Sep;42(9):1115-1117
pubmed: 33298211
Clin Microbiol Infect. 2021 Jan;27(1):61-66
pubmed: 33010444
BMC Infect Dis. 2021 Jan 14;21(1):74
pubmed: 33446122
Infect Prev Pract. 2021 Mar;3(1):100113
pubmed: 34316574
N Engl J Med. 2008 Mar 20;358(12):1271-81
pubmed: 18354105
Infect Control Hosp Epidemiol. 2021 Apr 16;:1-6
pubmed: 33858547
Curr Infect Dis Rep. 2018 Apr 27;20(6):12
pubmed: 29704133
Lancet Respir Med. 2020 May;8(5):506-517
pubmed: 32272080
PLoS One. 2021 May 11;16(5):e0251340
pubmed: 33974637
MMWR Morb Mortal Wkly Rep. 2020 Jan 10;69(1):6-9
pubmed: 31917780
J Clin Pharm Ther. 2006 Feb;31(1):67-72
pubmed: 16476122
Infect Control Hosp Epidemiol. 2021 Jan 05;:1-2
pubmed: 33397537
Emerg Infect Dis. 2021 Apr;27(4):1234-1237
pubmed: 33565961
Drugs. 2008;68(14):1941-62
pubmed: 18778118
Infect Drug Resist. 2021 May 24;14:1893-1903
pubmed: 34079300
Expert Opin Drug Saf. 2020 Jul;19(7):817-842
pubmed: 32394759
Infection. 2021 Jun 27;:
pubmed: 34176088
S Afr Med J. 2020 Jun 02;110(7):572-573
pubmed: 32880323
Microb Drug Resist. 2021 Sep;27(9):1167-1175
pubmed: 33600262
BMC Infect Dis. 2020 Sep 1;20(1):646
pubmed: 32873235
Sci Rep. 2020 Mar 27;10(1):5636
pubmed: 32221315
Front Cell Infect Microbiol. 2021 Mar 17;11:641920
pubmed: 33816347
Cell Host Microbe. 2020 Jun 10;27(6):992-1000.e3
pubmed: 32320677
J Clin Med. 2021 May 12;10(10):
pubmed: 34066031
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
Lancet Respir Med. 2021 Aug;9(8):e77
pubmed: 34090607
Med Mycol Case Rep. 2021 Mar;31:15-18
pubmed: 32837880
PLoS One. 2021 May 6;16(5):e0251170
pubmed: 33956882
Clin Microbiol Rev. 2017 Nov 15;31(1):
pubmed: 29142078
J Clin Microbiol. 2020 Dec 17;59(1):
pubmed: 33087440
Infect Control Hosp Epidemiol. 2003 Apr;24(4):284-95
pubmed: 12725359
Open Forum Infect Dis. 2020 Nov 12;7(11):ofaa518
pubmed: 33269299
Expert Rev Anti Infect Ther. 2020 Jun;18(6):551-562
pubmed: 32237924
J Antimicrob Chemother. 2019 Jul 1;74(7):2051-2054
pubmed: 31002313
Euro Surveill. 2019 Nov;24(46):
pubmed: 31771708

Auteurs

Francesco Vladimiro Segala (FV)

Clinic of Infectious Diseases, Catholic University of the Sacred Heart, 00168 Rome, Italy.

Davide Fiore Bavaro (DF)

Clinic of Infectious Diseases, University of Bari, 70121 Bari, Italy.

Francesco Di Gennaro (F)

Clinic of Infectious Diseases, University of Bari, 70121 Bari, Italy.

Federica Salvati (F)

Clinic of Infectious Diseases, Catholic University of the Sacred Heart, 00168 Rome, Italy.

Claudia Marotta (C)

General Directorate of Health Prevention, Ministry of Health, 00144 Rome, Italy.

Annalisa Saracino (A)

Clinic of Infectious Diseases, University of Bari, 70121 Bari, Italy.

Rita Murri (R)

Clinic of Infectious Diseases, Catholic University of the Sacred Heart, 00168 Rome, Italy.
Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

Massimo Fantoni (M)

Clinic of Infectious Diseases, Catholic University of the Sacred Heart, 00168 Rome, Italy.
Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH